Spyre Therapeutics, Inc. (SYRE): S-3ASR filed Jun 26, 2026

Form type

S-3ASR

Filing date

Jun 26, 2026

Accession number

0001628280-26-045742

Filer

Spyre Therapeutics, Inc. (CIK 1636282)